ArticleBlood advances2025

Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement.

Ibrahim N Muhsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.